Scotiabank Maintains Sector Perform on Sabra Health Care REIT, Raises Price Target to $18
Portfolio Pulse from Benzinga Newsdesk
Scotiabank analyst Nicholas Yulico maintains a Sector Perform rating on Sabra Health Care REIT (NASDAQ:SBRA) and raises the price target from $17 to $18.
October 11, 2024 | 2:28 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Scotiabank has maintained its Sector Perform rating on Sabra Health Care REIT and increased the price target from $17 to $18, indicating a positive outlook.
The increase in price target from $17 to $18 by Scotiabank suggests a positive outlook for Sabra Health Care REIT, which could lead to a short-term increase in stock price. The maintained Sector Perform rating indicates steady performance expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100